Multi-epitope T-cell Vaccine Shows Promise in Ovarian, Breast Cancer

Leggi l'articolo originale


TPIV200 stimulates T cells to attack ovarian and triple negative breast tumor cells that over-express the folate receptor alpha protein.

Lascia un commento